TAK-041

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTAK-041
Drug Alias NameTAK-041NBI-1065846
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProbable G-protein coupled receptor 139 agonists
TargetsProbable G-protein coupled receptor 139
Therapy Area/IndicationsSchizophreniaDepressive Disorder, MajorAnhedonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeurocrine Biosciences Inc
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsDepressive Disorder, MajorAnhedonia
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A